000 01553 a2200421 4500
005 20250516001610.0
264 0 _c20101105
008 201011s 0 0 eng d
022 _a1873-2968
024 7 _a10.1016/j.bcp.2010.08.017
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aVelasco-Loyden, Gabriela
245 0 0 _aPrevention of in vitro hepatic stellate cells activation by the adenosine derivative compound IFC305.
_h[electronic resource]
260 _bBiochemical pharmacology
_cDec 2010
300 _a1690-9 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdenosine
_xanalogs & derivatives
650 0 4 _aAnimals
650 0 4 _aCell Proliferation
_xdrug effects
650 0 4 _aCells, Cultured
650 0 4 _aGrowth Inhibitors
_xpharmacology
650 0 4 _aHepatic Stellate Cells
_xdrug effects
650 0 4 _aMale
650 0 4 _aRats
650 0 4 _aRats, Wistar
650 0 4 _aUp-Regulation
_xdrug effects
700 1 _aPérez-Carreón, Julio Isael
700 1 _aAgüero, José Fernando Cabello
700 1 _aRomero, Pilar Cabrales
700 1 _aVidrio-Gómez, Susana
700 1 _aMartínez-Pérez, Lidia
700 1 _aYáñez-Maldonado, Lucia
700 1 _aHernández-Muñoz, Rolando
700 1 _aMacías-Silva, Marina
700 1 _ade Sánchez, Victoria Chagoya
773 0 _tBiochemical pharmacology
_gvol. 80
_gno. 11
_gp. 1690-9
856 4 0 _uhttps://doi.org/10.1016/j.bcp.2010.08.017
_zAvailable from publisher's website
999 _c20146120
_d20146120